Dengying Wu
- Molecular Biology
- Rheumatology top 10%
- Cancer Research
- Pharmacology top 10%
- Oncology
- Topics
- Osteoarthritis Treatment and Mechanisms (6 papers)Natural product bioactivities and synthesis (6 papers)Biological Activity of Diterpenoids and Biflavonoids (3 papers)
- Partner nations
- ChinaCzechiaUnited States
In The Last Decade
Dengying Wu
12 papers receiving 487 citations
Peers
Comparison fields: 5 of 69
- Molecular Biology 309
- Rheumatology 134
- Cancer Research 133
- Pharmacology 92
- Oncology 43
Countries citing papers authored by Dengying Wu
This map shows the geographic impact of Dengying Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dengying Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dengying Wu more than expected).
Fields of papers citing papers by Dengying Wu
This network shows the impact of papers produced by Dengying Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dengying Wu. The network helps show where Dengying Wu may publish in the future.
Co-authorship network of co-authors of Dengying Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Dengying Wu. A scholar is included among the top collaborators of Dengying Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dengying Wu. Dengying Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 13 | |
| 5 | 85 | |
| 6 | 1 | |
| 7 | 31 | |
| 8 | 126 | |
| 9 | 33 | |
| 10 | 24 | |
| 11 | 49 | |
| 12 | 35 | |
| 13 | 35 | |
| 14 | 55 |
About Dengying Wu
Dengying Wu is a scholar working on Rheumatology, Pharmacology and Cancer Research, having authored 14 papers that have together received 489 indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (6 papers), Natural product bioactivities and synthesis (6 papers) and Biological Activity of Diterpenoids and Biflavonoids (3 papers). The work is most often cited by research in Rheumatology (134 citations), Cancer Research (133 citations) and Pharmacology (92 citations). Dengying Wu has collaborated with scholars based in China, Czechia and United States. Frequent co-authors include Jun Pan, Donghong Zhang, Lianpin Wu, Jinfeng Ning, Lin Zeng, Xiucui Li, Chao Jia, Rong Chen, Hongwei Lü and Ningyu Cai. Their work appears in journals such as Cell Death and Disease, Frontiers in Pharmacology and Oxidative Medicine and Cellular Longevity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.